Rezo Therapeutics
San Francisco, US · 3 known investors
Rezo Therapeutics is a drug discovery and development company focused on oncology and inflammation therapeutic areas. The company combines artificial intelligence, chemistry, and high-throughput wet lab experiments to advance small molecule drug candidates from discovery through clinical development.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
NK
Nevan KroganCo-Founder
SB
Sourav BandyopadhyayCo-Founder
NB
Norbert BischofbergerCo-Founder
NJ
Natalia JuraCo-Founder
GS
George ScangosCo-Founder
KS
Kevan ShokatCo-Founder
DH
Derek HicksChief Executive Officer
CG
Cristiana GuiducciChief Scientific Officer
CS
Chris SinzSenior Vice President of Drug Discovery
IG
Ivan GrubisicVice President of Computational Biology and AI
MR
Matthew R. PattersonChairman of the Board of Directors
Investors · 3
In the news
- Sell or Invest in Rezo Therapeutics Stock Pre-IPOnasdaqprivatemarket.com · 2025
- San Francisco California based Rezo Therapeutics is raising $80,129,936.00 in New Equity Investment. - intelligence360intelligence360.news · 2022
- UCSF researchers launch Rezo with $78 million in fundingcen.acs.org · 2022
- Rezo Therapeutics Raises $78M in Series A Fundingfinsmes.com · 2022
- Rezo Therapeutics, founded by renowned UCSF scientists, raises $78M in Series A — SR One Capital Managementclover-primrose-fe4p.squarespace.com · 2022